The model will help regulators, as well as the pharmaceutical industry, evaluate the best- and worst-case scenarios when hormonal contraceptives are prescribed with new drug candidates.
A four-year study aims to identify the patient groups who would benefit most from newer glucose-lowering drugs.
The project aims to identify barriers and facilitators to the enrollment and completion of the National Diabetes Prevention Program and evaluate its long-term effectiveness and cost-effectiveness.
Congratulations to the following UF College of Pharmacy faculty who were promoted and/or earned tenure on July 1, 2022.
The UF College of Pharmacy secured a record $32.3 million in research funding last year.
The honor recognizes individuals whose original research reflects new and relevant insights in geriatrics and who are committed to a career in aging research.
A modeling study published in JAMA Network Open estimates the years that might be added to the life span of someone with Type 2 diabetes with improved control of the disease.
Almut Winterstein, Ph.D., joined the From Florida podcast with Nicci Brown to discuss medical marijuana research.
Goodin has been appointed as a Center for Public Health Law Research Fellow for a two-year term.
The award recognizes Park for her excellence, innovation and effectiveness in mentoring doctoral students throughout their dissertation project.
